Drugs / Purethal
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT02440243 Comparator | Jan 2011 → Sep 2014 | allergic disease | Medical University of Silesia | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Purethal | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02440243 ↗ |
| Modality | Other / unclassified | “pollen mixture extract solution” NCT02440243 ↗ |
| Route | Subcutaneous | “specific subcutaneous immunotherapy (SCIT)” NCT02440243 ↗ |